| Product Name | MF | CAS | Details |
|---|
| MK-1775 | C27H32N8O2 | 955365-80-7 | Details |
| Ponatinib-HCl; AP24534-HCl | C29H28ClF3N6O | 1114544-31-8 | Details |
| CC-223 | C21H27N5O3 | 1228013-30-6 | Details |
| ABT-639 | C20H20ClF2N3O3S | 1235560-28-7 | Details |
| GSK591; EPZ-015866 | C22H28N4O2 | 1616391-87-7 | Details |
| MS023; MS-023 | C17H25N3O | 1831110-54-3 | Details |
| CHIR-090 | C24H27N3O5 | 728865-23-4 | Details |
| SH-4-54 | C29H27F5N2O5S | 1456632-40-8 | Details |
| EW-7197 | C22H18FN7 | 1352608-82-2 | Details |
| LY294002;LY-294002 | C19H17NO3 | 154447-36-6 | Details |
| Lasmiditan | C19H18F3N3O2 | 439239-90-4 | Details |
| MK-4101 | C24H24F5N5O | 935273-79-3 | Details |
| GDC-0084; GDC 0084 | C18H22N8O2 | 1382979-44-3 | Details |
| AG-221; Enasidenib | C19H17F6N7O | 1446502-11-9 | Details |
| BDA-366 | C24H29N3O4 | 1909226-00-1 | Details |
| GNE-3511 | C23H26F2N6O | 1496581-76-0 | Details |
| BP-1-102 | C29H27F5N2O6S | 1334493-07-0 | Details |
| XMD8-87 | C24H27N7O2 | 1234480-46-6 | Details |
| XMD16-5 | C23H24N6O2 | 1345098-78-3 | Details |
| RAF-709 | C28H29F3N4O4 | 1628838-42-5 | Details |
| Mivebresib; ABBV-075 | C22H19F2N3O4S | 1445993-26-9 | Details |
| BAY-876 | C24H16F4N6O2 | 1799753-84-6 | Details |
| SUN11602; SUN-11602 | C26H37N5O2 | 704869-38-5 | Details |
| Acebilustat | C29H27N3O4 | 943764-99-6 | Details |
| CP-21R7 | C19H15N3O2 | 125314-13-8 | Details |
| GSK-189254A | C21H25N3O2 | 720690-73-3 | Details |
| UK-371804; Urokinase inhitibor 1 | C14H16ClN5O4S | 256477-09-5 | Details |
| E 7449; E-7449 | C18H15N5O | 1140964-99-3 | Details |
| NCB-0846 | C21H21N5O2 | 1792999-26-8 | Details |
| ETP-46321 | C20H27N9O3S | 1252594-99-2 | Details |
| Q203 | C29H28ClF3N4O2 | 1334719-95-7 | Details |
| STK16-IN-1 | C17H12FN3O | 1223001-53-3 | Details |
| MK-4827 tosylate; Niraparib tosylate | C26H28N4O4S | 1038915-73-9 | Details |
| AMG-3969 | C21H20F6N4O3S | 1361224-53-4 | Details |
| GSK-2256098 | C20H23ClN6O2 | 1224887-10-8 | Details |
| GSK2982772 | C20H19N5O3 | 1622848-92-3 | Details |
| CPI-637 | C22H22N6O | 1884712-47-3 | Details |
| T0901317 | C17H12F9NO3S | 293754-55-9 | Details |
| NCGC00244536 | C25H22N2O2 | 2003260-55-5 | Details |
| GBT-440 | C19H19N3O3 | 1446321-46-5 | Details |
| SRT-2104 | C26H24N6O2S2 | 1093403-33-8 | Details |
| Pexidartinib | C20H15ClF3N5 | 1029044-16-3 | Details |
| Grapiprant | C26H29N5O3S | 415903-37-6 | Details |
| NVS-PAK1-1 | C23H25ClF3N5O | 1783816-74-9 | Details |
| Icotinib hydrochloride | C22H22ClN3O4 | 1204313-51-8 | Details |
| Lasmiditan hydrochloride | C19H19ClF3N3O2 | 613677-28-4 | Details |
| Lasmiditan hemisuccinate | C23H24F3N3O6 | 439239-92-6 | Details |
| OICR-9429 | C29H32F3N5O3 | 1801787-56-3 | Details |
| SH5-07; SH-5-07 | C29H28F5N3O5S | 1456632-41-9 | Details |
| 1-methyl-3-amino-4-cyanopyrazole | C5H6N4 | 21230-50-2 | Details |
| 6-bromo-[1,2,4]triazolo[1,5-a]pyridine | C6H4BrN3 | 356560-80-0 | Details |
| 2-(2-chloro-6-morpholino-9H-purin-8-yl)propan-2-ol | C12H16ClN5O2 | 1198171-62-8 | Details |
| GSK-3326595;EPZ-015938 | C24H32N6O3 | 1616392-22-3 | Details |
| Ticagrelor | C23H28F2N6O4S | 274693-27-5 | Details |
| All-rac-alfa-TocopherolEP impurity C | C29H50O2 | 10191-41-0 | Details |
| AZD7986 | C23 H24 N4 O4 | 1802148-05-5 | Details |
| 4-bromo-2-methoxyaniline | C7H8BrNO | 59557-91-4 | Details |
| 3-nitro-4-((tetrahydro-2H-pyran-4-yl)MethylaMino)benzenesulfonaMide | C12H17N3O5S | 1228779-96-1 | Details |
| Fevipiprant | C19H17F3N2O4S | 872365-14-5 | Details |
| CP-609754 (OSI754) | C29H22ClN3O2 | 1190094-64-4 | Details |
| (6-aminopyridin-2-yl)(1-methylpiperidin-4-yl)methanone hydrogen bromide | C12H16Br2N2O | 1338000-32-0 | Details |
| EPZ-015666;GSK3235025;GSK-3235025;EPZ-015666 | C20H25N5O3 | 1616391-65-1 | Details |
| Vipadenant; BIIB 014 | C16H15N7O | 442908-10-3 | Details |
| GS-9620 | C22H30N6O2 | 1228585-88-3 | Details |
| Defactinib: VS-6063: PF-04554878 | C20H21F3N8O3S | 1073154-85-4 | Details |
| Defactinib hydrochloride; VS-6063; PF-04554878 | C20H22ClF3N8O3S | 1073160-26-5 | Details |
| TAK-632; TAK-0632 | C27H18F4N4O3S | 1228591-30-7 | Details |
| UNC1215 | C32H43N5O2 | 1415800-43-9 | Details |
| BX-471; ZK-811752 | C21H24ClFN4O3 | 217645-70-0 | Details |
| PFI-3 | C19H19N3O2 | 1819363-80-8 | Details |
| ML324 | C21H23N3O2 | 1222800-79-4 | Details |
| AC 55541 | C25H20BrN5O3 | 916170-19-9 | Details |
| HTH-01-015 | C26H28N8O | 1613724-42-7 | Details |
| THZ1 | C31H28ClN7O2 | 1604810-83-4 | Details |
| Liproxstatin-1 | C19H21ClN4 | 950455-15-9 | Details |
| SKF-86002 | C16H12FN3S | 72873-74-6 | Details |
| AC-710 | C31H42N6O4 | 1351522-04-7 | Details |
| Emapunil; AC-5216 | C23H23N5O2 | 226954-04-7 | Details |
| SD-208 | C17H10ClFN6 | 627536-09-8 | Details |
| RGB-286638 | C29H35N7O4 | 784210-88-4 | Details |
| Pilaralisib; XL147 | C25H25ClN6O4S | 934526-89-3 | Details |
| SAR245408; XL-147 | C21H16N6O2S2 | 956958-53-5 | Details |
| GSK-163090 | C25H29N5O | 844903-58-8 | Details |
| UNC2025 | C28H40N6O | 1429881-91-3 | Details |
| Galeterone | C26H32N2O | 851983-85-2 | Details |
| AMG-319 | C21H16FN7 | 1608125-21-8 | Details |
| Motolimod; VTX-2337 | C28H34N4O2 | 926927-61-9 | Details |
| CEP-33779 | C24H26N6O2S | 1257704-57-6 | Details |
| MCC-950 Sodium | C20H24N2O5S | 210826-40-7 | Details |
| CWHM-12 | C26H32BrN5O6 | 1564286-55-0 | Details |
| MK-8776 | C15H18BrN7 | 891494-64-7 | Details |
| Binimetinib; MEK-162; ARRY-162;ARRY-438162 | C17H15BrF2N4O3 | 606143-89-9 | Details |
| Coelenterazine | C26H21N3O3 | 55779-48-1 | Details |
| Product Total： Product Page： | ||||
| 1 | ||||